Clovis Oncology (CLVS)
Add to Watchlists Create an AlertClovis Oncology Operating PE Ratio TTM
Clovis Oncology Operating PE Ratio TTM Chart
View Operating PE Ratio TTM for CLVS.
Start Your YCharts Pro Gold Membership.
Clovis Oncology Historical Operating PE Ratio TTM Data
Pro Data ExportThere is no data for the selected date range.
About Operating PE Ratio
Click the "Learn More" link below to see how we calculate operating earnings yield.
The Operating PE Ratio is the price an investor pays for one dollar of pre-tax operating earnings.
It is similar to a standard PE Ratio, but some investors consider it a better indicator of future earning power than earnings yield since the earnings number excludes tax effects, non-operating income and expenses, discontinued operations, extraordinary items, preferred stock dividends and accounting change differences.
Learn More
View Operating PE Ratio TTM for CLVS.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
CLVS Operating PE Ratio TTM Benchmarks
| Companies | |
|---|---|
| Coronado Biosciences | Go Pro |
| Halozyme Therapeutics | Go Pro |
| Infinity Pharmaceuticals | Go Pro |
